- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Primary Care Physicians' Views of Medicare Part DPrimary care physicians have mixed views of prescription drug coverage under Medicare Part D.
Latest:
Breast Cancer Multigene Testing Trends and Impact on Chemotherapy UseA multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Latest:
Innovative Payment to Scale Up Access to Medications for Opioid Use DisorderBundled payments offer promise as a supplement to existing payment models to promote scaling up of opioid use disorder treatment using buprenorphine.
Latest:
Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients With Schizophrenia and Bipolar Disorder in MedicaidRetrospective analysis of medical and pharmacy claims for patients diagnosed with schizophrenia or bipolar disorder in 24 state Medicaid programs.
Latest:
Quality of Anticoagulation Control Among Patients With Atrial FibrillationPatients with atrial fibrillation receiving routine medical care within a large managed care organization were found to have suboptimal anticoagulation control.
Latest:
Process of Care Compliance Is Associated With Fewer Diabetes ComplicationsAdherence to process of care measures was associated with reduced risk of 2 diabetes complications or any of 4 complications in a national industrial cohort.
Latest:
Moving From A to Z: Successful Implementation of a Statin Switch Program by a Large Physician GroupThis report shows that a successful, cost-effective statin switch program can be implemented by a large physician group via a centralized, collaborative process.
Latest:
Trends in Mortality Following Hip Fracture in Older WomenWithin an integrated healthcare setting, temporal trends demonstrate reductions in mortality risk after hip fracture in older women, with mortality risk lower for Asians and Hispanics.
Latest:
The Vermedx® Diabetes Information System Reduces Healthcare UtilizationThis analysis of paid claims from a physician hospital organization demonstrates that the Vermedx Diabetes Information System improves healthcare costs for adults with diabetes.
Latest:
Communication of Launch Prices by Drug Companies, 2022-2024Two-thirds of pharmaceutical companies did not proactively release the launch price of their medications from 2022 to 2024.
Latest:
Multilevel Predictors of Colorectal Cancer Screening Use in CaliforniaWe studied contextual factors and found that locality, availability of primary care, and HMO membership influenced use of colorectal cancer screening in California.
Latest:
Using Simulation to Identify and Resolve Threats to Patient SafetyThe same simulation methodology used in the aviation industry was able to uncover latent environmental threats to patient safety.
Latest:
Modes of Delivery for Interventions to Improve Cardiovascular Medication AdherenceIn this review of randomized controlled trials designed to improve adherence to cardiovascular medications, electronic interventions and in-person, pharmacy-based interventions showed the highest success rates.
Latest:
Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-PaclitaxelWe examine the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.
Latest:
Outpatient-Shopping Behavior and Survival Rates in Newly Diagnosed Cancer PatientsHigher incomes, higher comorbidity scores, and more advanced cancer were associated with outpatient-shopping behavior in Taiwanese patients.
Latest:
Hydroxychloroquine Ineffective in Treating Hand Osteoarthritis Compared With PlaceboHydroxychloroquine (HCQ) showed no signs of effectiveness when compared with a placebo with an indication to relieve moderate to severe hand pain and radiographic osteoarthritis, according to a randomized trial published in Annals of Internal Medicine.
